Plasma neurofilament light chain concentrations as a biomarker of clinical and radiologic outcomes in relapsing multiple sclerosis: Post hoc analysis of Phase 3 ozanimod trials
- DOI
- 10.1111/ene.15009
- Published
- 2021-08-23
- Container
- European Journal of Neurology
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1111/ene.15009,
title = {Plasma neurofilament light chain concentrations as a biomarker of clinical and radiologic outcomes in relapsing multiple sclerosis: Post hoc analysis of Phase 3 ozanimod trials},
author = {Sarah Harris and Giancarlo Comi and Bruce A. C. Cree and Douglas L. Arnold and Lawrence Steinman and James K. Sheffield and Harry Southworth and Ludwig Kappos and Jeffrey A. Cohen and Unknown},
year = {2021},
journal = {European Journal of Neurology},
doi = {10.1111/ene.15009},
url = {https://doi.org/10.1111/ene.15009}
}RIS
TY - JOUR TI - Plasma neurofilament light chain concentrations as a biomarker of clinical and radiologic outcomes in relapsing multiple sclerosis: Post hoc analysis of Phase 3 ozanimod trials AU - Sarah Harris AU - Giancarlo Comi AU - Bruce A. C. Cree AU - Douglas L. Arnold AU - Lawrence Steinman AU - James K. Sheffield AU - Harry Southworth AU - Ludwig Kappos AU - Jeffrey A. Cohen AU - Unknown PY - 2021 JO - European Journal of Neurology DO - 10.1111/ene.15009 UR - https://doi.org/10.1111/ene.15009 ER -
APA
Harris, S., Comi, G., Cree, B. A. C., Arnold, D. L., Steinman, L., Sheffield, J. K., Southworth, H., Kappos, L., Cohen, J. A., & Unknown (2021). Plasma neurofilament light chain concentrations as a biomarker of clinical and radiologic outcomes in relapsing multiple sclerosis: Post hoc analysis of Phase 3 ozanimod trials. European Journal of Neurology. https://doi.org/10.1111/ene.15009
Source records
- crossref · retrieved 2026-09-25T04:23:48.283Z